Form 13-F position report

ANEBULO PHARMACEUTICALS INC

Reported by PNC FINANCIAL SERVICES GROUP INC

ANEB CUSIP 034569103 Manager CIK 0000713676

Reported 0 shares, down 1,528 (100.0%) from the prior quarter.

Reported value -100.0%; share count -100.0% vs. the prior quarter.

Reduced
% of reported 13F value 0 This manager · Q3 2025
Shares 0 Quarter-end amount reported
Reported value $0 Fair value at quarter end
Consecutive quarters held 2 Through Q3 2025

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Reported position value by quarter
Date Holding Value
2025-06-30 2200
2025-09-30 0

Quarterly position history

How this manager's reported quarter-end position changed over time.

2 quarters
Quarterly reported position history for ANEBULO PHARMACEUTICALS INC held by PNC FINANCIAL SERVICES GROUP INC.
Quarter Activity Shares Change % of reported 13F Reported value Filed Source filing
Q3 2025 Reduced 0 -1,528 (-100.0%) 0 $0 2025-11-07
Q2 2025 New 1,528 +1,528 (0.0%) < 0.01% $2,200 2025-08-08

Who else reported the position

27 managers reported ANEBULO PHARMACEUTICALS INC for Q3 2025.

Managers reporting ANEBULO PHARMACEUTICALS INC in Q3 2025.
Manager Activity Shares Change % of reported 13F Reported value Tenure
22NW LP Unchanged 15,467,300 0 18.22% $38,668,250 18 qtrs
Nantahala Capital Management LLC Unchanged 3,036,325 0 0.26% $7,590,812 13 qtrs
MANGROVE PARTNERS Unchanged 2,525,252 0 0.47% $6,313,130 4 qtrs
MORGAN STANLEY Added 399,404 +185 < 0.01% $998,511 8 qtrs
VANGUARD GROUP INC Added 306,540 +90,589 < 0.01% $766,351 10 qtrs
GEODE CAPITAL MANAGEMENT LLC Reduced 174,108 -31,612 < 0.01% $435,570 7 qtrs
Ikarian Capital LLC Unchanged 157,720 0 0.04% $394,300 18 qtrs
RENAISSANCE TECHNOLOGIES LLC New 28,500 +28,500 < 0.01% $71,250 1 qtr
NORTHERN TRUST CORPORATION New 24,393 +24,393 < 0.01% $60,983 1 qtr
BlackRock Inc Added 24,060 +6,847 < 0.01% $60,150 5 qtrs
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
September 30, 2025
Filed
November 07, 2025
Filing type
13F-HR
Position type
COM

Voting authority reported

No voting-authority amounts were reported for this position. Voting authority is not required for reported call options.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.